About PROTO SCRIPT PHARMACEUTICAL CORP
Sector
Industry
CEO
Michelle Rico
Headquarters
Rancho Cucamonga
Founded
2001
ISIN
US74373V1052
FIGI
BBG001V46490
Proto Script Pharmaceutical Corp. engages in the provision of mobility solutions. It deals with federal, state, and private insurance providers to provide repair and rental of power wheelchairs and scooters. The firm's services include Financing Mobility Equipment and In-House Financing. The company was founded on June 27, 2001 and is headquartered in Rancho Cucamonga, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PSCR is 0.0002 USD — it has increased by 19.90 K% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PROTO SCRIPT PHARMACEUTICAL CORP stocks are traded under the ticker PSCR.
PSCR stock is 99.50% volatile and has beta coefficient of −38.87. Check out the list of the most volatile stocks — is PROTO SCRIPT PHARMACEUTICAL CORP there?
Yes, you can track PROTO SCRIPT PHARMACEUTICAL CORP financials in yearly and quarterly reports right on TradingView.
No, PSCR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PSCR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROTO SCRIPT PHARMACEUTICAL CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROTO SCRIPT PHARMACEUTICAL CORP technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROTO SCRIPT PHARMACEUTICAL CORP stock shows the sell signal. See more of PROTO SCRIPT PHARMACEUTICAL CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.